Trump signs order raising Canada tariffs to 35% from 25%
Director Liliana Gil Valletta of Zumiez Inc (NASDAQ:ZUMZ) sold 6,600 shares of common stock on June 26, 2025, for $12.8215 each, in one transaction. The sale comes as Zumiez shares have declined over 35% in the past six months, trading near $12.83, significantly below their 52-week high of $31.37. According to InvestingPro data, the company maintains a FAIR financial health score of 2.02.
The total value of the sale amounted to $84,621. Following the transaction, Valletta directly owns 10,809 shares of Zumiez Inc, representing a small portion of the company’s $227 million market capitalization. For deeper insights into insider transactions and comprehensive analysis, InvestingPro subscribers can access the full Pro Research Report, which includes detailed financial health metrics and expert analysis.
In other recent news, Zumiez Inc. reported its financial results for the first quarter of 2025, revealing a mixed performance. The company saw its earnings per share (EPS) slightly miss forecasts at -$0.79, compared to the expected -$0.78. However, revenue exceeded expectations, reaching $184.3 million, surpassing the anticipated $182.23 million. During the annual shareholder meeting, Zumiez shareholders elected Travis D. Smith and Guy M. Harkless to the board of directors and approved executive compensation and the appointment of Moss Adams LLP as the independent accounting firm for the fiscal year ending January 31, 2026.
Zumiez also announced a new share repurchase program authorized by the board for up to $15 million. The company highlighted a 3.9% increase in net sales compared to the same period in 2024, with a 5.5% growth in comparable sales. Analysts noted that Zumiez’s strategic focus on product curation and brand partnerships continues to support its market position. Furthermore, Zumiez plans to reduce its reliance on China for sourcing, aiming for a 30% exposure by year-end. Looking ahead, Zumiez provided guidance for the second quarter of 2025, anticipating total sales between $207 million and $214 million, with expectations of modest product margin growth.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.